Recent in vitro studies showed that LDB2 inhibited the proliferation and migration of hepatocarcinoma cells and that LDB2 expression can be upregulated by the m6A reader YTH Domain Containing 2 (YTHDC2) in lung adenocarcinoma to inhibit the proliferation of tumor cells [13]. This evidence concerns the gene LDB2 and lung adenocarcinoma.